Irvine, CA, United States of America

Ton Lin

USPTO Granted Patents = 9 


 

Average Co-Inventor Count = 7.3

ph-index = 4

Forward Citations = 75(Granted Patents)


Location History:

  • Irvine, CA (US) (2012 - 2015)
  • Mission Viejo, CA (US) (2019)

Company Filing History:


Years Active: 2012-2019

Loading Chart...
Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Ton Lin

Introduction

Ton Lin is a prominent inventor based in Irvine, California, known for his significant contributions to the field of ocular health. With a total of nine patents to his name, Lin has made remarkable advancements in the development of intraocular implants that address various ocular conditions.

Latest Patents

One of Lin's latest patents focuses on sustained release intraocular implants and methods for treating ocular vasculopathies. These biocompatible implants incorporate an alpha-2 adrenergic receptor agonist along with a polymer that facilitates the controlled release of the agonist into the eye over an extended period. The alpha-2 adrenergic receptor agonist is often associated with a biodegradable polymer matrix, which may consist of two biodegradable polymers. These innovative implants are designed to be placed in the eye to treat conditions such as ocular vasculopathy and glaucoma, among others.

Career Highlights

Ton Lin has established a successful career at Allergan, Inc., where he has been instrumental in advancing ocular treatment technologies. His work has not only contributed to the company's portfolio but has also significantly impacted patient care in the field of ophthalmology.

Collaborations

Throughout his career, Lin has collaborated with esteemed colleagues, including Glenn T. Huang and James A. Burke. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas, further enhancing the development of effective

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…